Pancreatic Cancer Research

ResearcherCancer Research UK Scotland InstituteNo recent work listed

Declan Whyte

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-0705-2296; OpenAlex author ID A5010386483. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. NUAK1 governs centrosome replication in pancreatic cancer via MYPT1/PP1β and GSK3β-dependent regulation of PLK4. Co-author DOI 10.1002/1878-0261.13425↗
  2. Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-19-0620↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel J. Murphy · 2 shared papers, 2020–2023 · strength 0.25
  2. Jennifer P. Morton · 2 shared papers, 2020–2023 · strength 0.25
  3. Nathiya Muthalagu · 2 shared papers, 2020–2023 · strength 0.25
  4. Martin Bushell · 1 shared paper, 2023 · strength 0.17
  5. Owen James Sansom · 1 shared paper, 2020 · strength 0.08
  6. Andrew Victor Biankin · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.